HemaSphere

ISSN: 2572-9241
Publisher: Lippincott, Williams & Wilkins

Publications (14)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience (2024) Innocenti I, Mosca A, Tomasso A, Galitzia A, Scarfò L, Morelli F, Galli E, et al. Journal article How to put a hex on HOX (2024) Slany R Journal article Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade (2024) Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, et al. Journal article Models for the marrow: A comprehensive review of AI-based cell classification methods and malignancy detection in bone marrow aspirate smears. (2024) Ghete T, Kock F, Pontones M, Pfrang D, Westphal M, Höfener H, Metzler M Journal article, Review article Inferior Outcomes of EU Versus US Patients Treated with CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use (2023) Bücklein V, Perez A, Rejeski K, Iacoboni G, Jurinovic V, Holtick U, Penack O, et al. Journal article Identifying Early Infections in the Setting of CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL (2023) Rejeski K, Blumenberg V, Iacoboni G, Lopez-Corral L, Kharboutli S, Hernani R, Petrera A, et al. Journal article The eha research roadmap: Infections in hematology (2021) Cordonnier C, Ljungman P, Cesaro S, Hirsch HH, Maschmeyer G, Von Lilienfeld-Toal M, Vehreschild M, et al. Journal article, Review article Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future (2021) Heine R, Thielen FW, Koopmanschap M, Kersten MJ, Einsele H, Jaeger U, Sonneveld P, et al. Journal article The EHA research Roadmap: Immune-based therapies for hematological malignancies (2021) Einsele H, Briones J, Ciceri F, Garcia Cadenas I, Falkenburg F, Bolanos N, Heemskerk HMM, et al. Journal article, Review article